Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Gastrointestinal Neoplasms 3 Esophageal Neoplasms 2 Stomach Neoplasms 1 Sarcoma 1 Peritoneal Neoplasms 1 Pelvic Neoplasms 1 Osteosarcoma 1 Head and Neck Neoplasms 1 Endometrial Neoplasms 1 Appendiceal Neoplasms 1

Interventions

Doxorubicin 15 pembrolizumab 12 Surgical Procedures, Operative 8 Cyclophosphamide 8 Blood Specimen Collection 8 Ifosfamide 7 Gemcitabine 7 Surveys and Questionnaires 6 Nivolumab 6 Trabectedin 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Drug Therapy 5 atezolizumab 4 Temozolomide 4 Specimen Handling 4 Radiation Dose Hypofractionation 4 Biopsy 4 pazopanib 3 liposomal doxorubicin 3 fludarabine 3 cabozantinib 3 anlotinib 3 Radiation 3 Observation 3 Docetaxel 3 Dacarbazine 3 trastuzumab deruxtecan 2 toripalimab 2 selinexor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sarcoma × Pafolacianine × Clear all

NCT06235125 2026-06-05

Cytalux

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1 Recruiting

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡